{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:06:14Z","timestamp":1781931974773,"version":"3.54.5"},"reference-count":66,"publisher":"Houston Methodist DeBakey Heart & Vascular Center","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,6]]},"DOI":"10.14797\/mdcvj.1136","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T10:57:36Z","timestamp":1662461856000},"page":"73-85","source":"Crossref","is-referenced-by-count":12,"title":["When Prevention is Truly Better than Cure: Contrast-Associated Acute Kidney Injury in Percutaneous Coronary Intervention"],"prefix":"10.14797","volume":"18","author":[{"given":"Tea","family":"Isaac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salima","family":"Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4334-8133","authenticated-orcid":false,"given":"Neal S.","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5826","reference":[{"issue":"12","key":"key20220906065731_B1","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1097\/01.ASN.0000095642.25603.7A","article-title":"Association between renal insufficiency and inducible ischemia in patients with coronary artery disease: the heart and soul study","volume":"14","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"key20220906065731_B2","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1097\/01.ASN.0000135121.81744.75","article-title":"Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial","volume":"15","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"9731","key":"key20220906065731_B3","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"key20220906065731_B4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"key20220906065731_B5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0735-1097(02)02663-3","article-title":"Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community","volume":"41","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"key20220906065731_B6","first-page":"748","article-title":"Complete anuria due to blockage of renal tubules by protein casts in a case of multiple myeloma","volume":"27","year":"1939","journal-title":"Arch Path"},{"issue":"2","key":"key20220906065731_B7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cjca.2015.05.013","article-title":"Contrast-Induced Nephropathy: From Pathophysiology to Preventive Strategies","volume":"32","year":"2016","journal-title":"Can J Cardiol"},{"issue":"1","key":"key20220906065731_B8","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.12121823","article-title":"Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?","volume":"267","year":"2013","journal-title":"Radiology"},{"key":"key20220906065731_B9","article-title":"Acute Kidney Injury After Radial or Femoral Access for Invasive Acute Coronary Syndrome Management: AKI-MATRIX","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"key20220906065731_B10","first-page":"69","article-title":"Kidney Int Suppl (2011)","volume":"2","author":"Section 4: Contrast-induced AKI","year":"2012"},{"issue":"3","key":"key20220906065731_B11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ccd.10534","article-title":"Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine","volume":"59","year":"2003","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"key20220906065731_B12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ahj.2005.03.018","article-title":"Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention","volume":"151","year":"2006","journal-title":"Am Heart J"},{"issue":"6A","key":"key20220906065731_B13","first-page":"5K","article-title":"Epidemiology and prognostic implications of contrast-induced nephropathy","volume":"98","year":"2006","journal-title":"Am J Cardiol"},{"issue":"19","key":"key20220906065731_B14","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"key20220906065731_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2013.06.016","article-title":"Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry","volume":"7","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"key20220906065731_B16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ccd.1093","article-title":"Acute renal failure requiring dialysis after percutaneous coronary interventions","volume":"52","year":"2001","journal-title":"Catheter Cardiovasc Interv"},{"issue":"3","key":"key20220906065731_B17","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ccd.21619","article-title":"Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry","volume":"72","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"issue":"7","key":"key20220906065731_B18","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jcin.2021.11.026","article-title":"Long-Term Clinical Impact of Contrast-Associated Acute Kidney Injury Following PCI: An ADAPT-DES Substudy","volume":"15","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"key20220906065731_B19","first-page":"93","article-title":"Renal vasoconstriction after low and high osmolar contrast agents in ischemic and non ischemic canine kidney","volume":"36","year":"1991","journal-title":"Clin Nephrol"},{"issue":"5","key":"key20220906065731_B20","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00004424-196809000-00002","article-title":"Renal hemodynamic effects of contrast media","volume":"3","year":"1968","journal-title":"Invest Radiol"},{"issue":"13","key":"key20220906065731_B21","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.05.099","article-title":"Contrast-Induced Acute Kidney Injury","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2 Pt 2","key":"key20220906065731_B22","first-page":"F246","article-title":"Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells","volume":"252","year":"1987","journal-title":"Am J Physiol"},{"issue":"3","key":"key20220906065731_B23","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijcard.2007.05.004","article-title":"Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine","volume":"126","year":"2008","journal-title":"Int J Cardiol"},{"issue":"1","key":"key20220906065731_B24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjcard.2004.08.056","article-title":"Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables","volume":"95","year":"2005","journal-title":"Am J Cardiol"},{"issue":"5","key":"key20220906065731_B25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0002-9343(97)00150-2","article-title":"Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality","volume":"103","year":"1997","journal-title":"Am J Med"},{"issue":"3","key":"key20220906065731_B26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM198901193200303","article-title":"Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study","volume":"320","year":"1989","journal-title":"N Engl J Med"},{"issue":"1","key":"key20220906065731_B27","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ki.1995.32","article-title":"Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study","volume":"47","year":"1995","journal-title":"Kidney Int"},{"issue":"4","key":"key20220906065731_B28","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11255-012-0340-8","article-title":"Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions","volume":"45","year":"2013","journal-title":"Int Urol Nephrol"},{"key":"key20220906065731_B29","first-page":"423848","article-title":"ACE-I\/ARB therapy prior to contrast exposure: what should the clinician do?","volume":"2014","year":"2014","journal-title":"Biomed Res Int"},{"issue":"1","key":"key20220906065731_B30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ahj.2015.04.019","article-title":"Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor\/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial","volume":"170","year":"2015","journal-title":"Am Heart J"},{"issue":"6","key":"key20220906065731_B31","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.athoracsur.2018.01.010","article-title":"Major adverse renal and cardiac events after coronary angiography and cardiac surgery","volume":"105","year":"2018","journal-title":"Ann Thorac Surg"},{"issue":"7","key":"key20220906065731_B32","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"key20220906065731_B33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00392-009-0058-5","article-title":"Contrast medium induced nephropathy in patients undergoing percutaneous coronary intervention for acute coronary syndrome: differences in STEMI and NSTEMI","volume":"98","year":"2009","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"key20220906065731_B34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.carrev.2017.02.017","article-title":"Effects of staged versus ad hoc percutaneous coronary interventions on renal function-Is there a benefit to staging?","volume":"18","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"issue":"1","key":"key20220906065731_B35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2007.09.019","article-title":"Ultra-low contrast volumes reduce rates of contrast-induced nephropathy in patients with chronic kidney disease undergoing coronary angiography","volume":"51","year":"2008","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"key20220906065731_B36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/ccd.27819","article-title":"Contemporary use of and outcomes associated with ultra-low contrast volume in patients undergoing percutaneous coronary interventions","volume":"93","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"16","key":"key20220906065731_B37","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/eurheartj\/ehr494","article-title":"Contrast-induced kidney injury: mechanisms, risk factors, and prevention","volume":"33","year":"2012","journal-title":"Eur Heart J"},{"issue":"22","key":"key20220906065731_B38","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.jacc.2013.03.026","article-title":"A novel tool for reliable and accurate prediction of renal complications in patients undergoing percutaneous coronary intervention","volume":"61","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20220906065731_B39","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCINTERVENTIONS.110.955310","article-title":"Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction","volume":"3","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"10315","key":"key20220906065731_B40","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(21)02326-6","article-title":"A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"key20220906065731_B41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12928-020-00660-8","article-title":"Contrast-induced acute kidney injury","volume":"35","year":"2020","journal-title":"Cardiovasc Interv Ther"},{"issue":"19","key":"key20220906065731_B42","first-page":"1877","article-title":"JACC Cardiovasc Interv","volume":"12","year":"2019"},{"issue":"9931","key":"key20220906065731_B43","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"key20220906065731_B44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcin.2015.09.026","article-title":"Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients","volume":"9","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"key20220906065731_B45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0002-9149(01)02243-3","article-title":"Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)","volume":"89","year":"2002","journal-title":"Am J Cardiol"},{"key":"key20220906065731_B46","unstructured":"ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2022. Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program (RaPPID); 2022 Mar 21 [cited 2022 Aug 1]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03719170"},{"issue":"21","key":"key20220906065731_B47","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM199411243312104","article-title":"Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"issue":"7","key":"key20220906065731_B48","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"key20220906065731_B49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","year":"2019","journal-title":"Eur Heart J"},{"issue":"24","key":"key20220906065731_B50","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"58","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"key20220906065731_B51","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.111.030759","article-title":"Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury","volume":"124","year":"2011","journal-title":"Circulation"},{"issue":"17","key":"key20220906065731_B52","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jcin.2020.04.051","article-title":"Left ventricular end-diastolic pressure versus urine flow rate\u2013guided hydration in preventing contrast-associated acute kidney injury","volume":"13","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"5","key":"key20220906065731_B53","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ahj.2014.08.005","article-title":"Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study","volume":"168","year":"2014","journal-title":"Am Heart J"},{"issue":"1","key":"key20220906065731_B54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2011.03.001","article-title":"Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial","volume":"108","year":"2011","journal-title":"Am J Cardiol"},{"issue":"2","key":"key20220906065731_B55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4065\/79.2.211","article-title":"Contrast nephropathy after coronary angiography","volume":"79","year":"2004","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"key20220906065731_B56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCINTERVENTIONS.109.910638","article-title":"Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?","volume":"3","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"issue":"40","key":"key20220906065731_B57","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1093\/eurheartj\/ehw078","article-title":"Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study","volume":"37","year":"2016","journal-title":"Eur Heart J"},{"issue":"13_Supplement","key":"key20220906065731_B58","first-page":"B32","article-title":"TCT-32 clinical outcomes of imaging-and physiology-guided PCI without contrast administration in advanced renal failure","volume":"74","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20220906065731_B59","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1253\/circj.CJ-21-0905","article-title":"Feasibility, Safety, and Long-Term Outcomes of Zero-Contrast Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease","volume":"86","year":"2022","journal-title":"Circ J"},{"key":"key20220906065731_B60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2016.11.170","article-title":"Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials","volume":"228","year":"2017","journal-title":"Int J Cardiol"},{"key":"key20220906065731_B61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2018.08.097","article-title":"Incidence of contrast-induced acute kidney injury in a large cohort of all-comers undergoing percutaneous coronary intervention: Comparison of five contrast media","volume":"273","year":"2018","journal-title":"Int J Cardiol"},{"issue":"1","key":"key20220906065731_B62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.amjcard.2013.08.040","article-title":"Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrast-induced nephropathy","volume":"113","year":"2014","journal-title":"Am J Cardiol"},{"issue":"7","key":"key20220906065731_B63","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ccd.27935","article-title":"Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert\u2122 plus contrast reduction system","volume":"93","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"11","key":"key20220906065731_B64","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jcin.2014.05.024","article-title":"Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial","volume":"7","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"key20220906065731_B65","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.116.309738","article-title":"Hemodynamic Support With a Microaxial Percutaneous Left Ventricular Assist Device (Impella) Protects Against Acute Kidney Injury in Patients Undergoing High-Risk Percutaneous Coronary Intervention","volume":"120","year":"2017","journal-title":"Circ Res"},{"issue":"6","key":"key20220906065731_B66","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/ccd.28400","article-title":"Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study","volume":"95","year":"2020","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["Methodist DeBakey Cardiovascular Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T10:58:51Z","timestamp":1662461931000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.houstonmethodist.org\/articles\/10.14797\/mdcvj.1136\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,9,6]]}},"alternative-id":["10.14797\/mdcvj.1136"],"URL":"https:\/\/doi.org\/10.14797\/mdcvj.1136","relation":{},"ISSN":["1947-6108"],"issn-type":[{"value":"1947-6108","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]}}}